|
|
|
|
|
|
|
Poster: 264
Visits: 66
Title: Preclinical evaluation of the novel pleiotropic BCR kinase inhibitor IQS019 in in vitro and in vivo models of B lymphoid neoplasms
Authors: Gael Roue ,
Centre: IDIBAPS
|
|
You must be registered to reply or comment.
|
|
PRECLINICAL EVALUATION OF THE NOVEL PLEIOTROPIC BCR KINASE INHIBITOR IQS019 IN IN VITRO AND IN VIVO MODELS OF B LYMPHOID NEOPLASMS
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 274
Visits: 159
Title: Novel CD37-Targeting Antibody-Drug Conjugate (ADC), IMGN529, Has Synergistic Activity in Combination with Rituximab in Non-Hodgkin Lymphoma (NHL) Models
Authors: Angela Romanelli , JF Ponte, J Deckert, K OCallaghan, JA Coccia, L Lanieri, S Chicklas, R Ruiz-Soto
Centre: ImmunoGen Inc
|
|
|
|